Associations of serum CRP levels with demographics, health behaviors, and risk of cancer among the Mexican American Mano A Mano Cohort.

[1]  C. Sabiston,et al.  Changes in physical activity behavior and C-reactive protein in breast cancer patients , 2018, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[2]  I. Romieu,et al.  Soda Intake Is Directly Associated with Serum C-Reactive Protein Concentration in Mexican Women. , 2018, The Journal of nutrition.

[3]  H. Lan,et al.  C‐reactive protein and ageing , 2017, Clinical and experimental pharmacology & physiology.

[4]  Xifeng Wu,et al.  Cohort Profile: The Mexican American Mano a Mano Cohort. , 2017, International journal of epidemiology.

[5]  J. Jeon,et al.  Effects of Exercise on Insulin, IGF Axis, Adipocytokines, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-analysis , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[6]  A. Kengne,et al.  Serum hs-CRP varies with dietary cholesterol, but not dietary fatty acid intake in individuals free of any history of cardiovascular disease , 2016, European Journal of Clinical Nutrition.

[7]  C. Friedenreich,et al.  Inflammatory Marker Changes in Postmenopausal Women after a Year-long Exercise Intervention Comparing High Versus Moderate Volumes , 2015, Cancer Prevention Research.

[8]  L. Pączek,et al.  Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges , 2015, Archivum Immunologiae et Therapiae Experimentalis.

[9]  I. Romieu,et al.  Endogenous hormones, inflammation, and body size in premenopausal Mexican women: results from the Mexican Teachers’ Cohort (MTC, ESMaestras) , 2015, Cancer Causes & Control.

[10]  F. Clavel-Chapelon,et al.  C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study , 2014, Cancer Causes & Control.

[11]  P. Ridker,et al.  A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. , 2013, American journal of epidemiology.

[12]  A Sicras-Mainar,et al.  C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice , 2013, European Psychiatry.

[13]  L. Joseph,et al.  Obesity and C‐reactive protein in various populations: a systematic review and meta‐analysis , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[14]  Yurii B. Shvetsov,et al.  Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer , 2013, Cancer Prevention Research.

[15]  K Sakata,et al.  Effect of high-sensitivity C-reactive protein on the development of diabetes as demonstrated by pooled logistic-regression analysis of annual health-screening information from male Japanese workers. , 2013, Diabetes & metabolism.

[16]  Seung-Pyo Lee,et al.  Can C-reactive protein predict cardiovascular events in asymptomatic patients? Analysis based on plaque characterization. , 2012, Atherosclerosis.

[17]  Sameer M. Siddiqi,et al.  Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.

[18]  M. Lehtinen,et al.  Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  T. McDade,et al.  Predictors of C-reactive protein in the national social life, health, and aging project. , 2011, The journals of gerontology. Series B, Psychological sciences and social sciences.

[20]  F. Clavel-Chapelon,et al.  Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study , 2010, Endocrine-related cancer.

[21]  M. Blaha,et al.  Relation of C-reactive protein to abdominal adiposity. , 2010, The American journal of cardiology.

[22]  D. Sbarra.  Marriage Protects Men from Clinically Meaningful Elevations in C-Reactive Protein: Results from the National Social Life, Health, and Aging Project (NSHAP) , 2009, Psychosomatic medicine.

[23]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[24]  Ross J. Harris,et al.  Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis , 2009, Cancer Causes & Control.

[25]  E. McCarthy,et al.  Obesity and C‐reactive Protein Levels Among White, Black, and Hispanic US Adults , 2008, Obesity.

[26]  Lee-Ming Chuang,et al.  Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men. , 2007, Diabetes research and clinical practice.

[27]  M. Criqui,et al.  Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. , 2006, American heart journal.

[28]  P. Ridker,et al.  C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? , 2006, Circulation.

[29]  E. Rimm,et al.  Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. , 2006, Atherosclerosis.

[30]  A. Trichopoulou,et al.  Plasma C-Reactive Protein and Risk of Cancer: A Prospective Study from Greece , 2006, Cancer Epidemiology Biomarkers & Prevention.

[31]  K. Courneya,et al.  Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: A randomized controlled trial , 2005, Brain, Behavior, and Immunity.

[32]  P. Libby,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. , 2004, Circulation.

[33]  Nader Rifai,et al.  Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. , 2004, Journal of the American College of Cardiology.

[34]  N. Rifai,et al.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group , 2004, Circulation.

[35]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[36]  K. Kayaba,et al.  Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study. , 2001, American journal of epidemiology.

[37]  Hermann Brenner,et al.  Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.

[38]  J. Olshaker,et al.  The C-reactive protein. , 1999, The Journal of emergency medicine.

[39]  R J Glynn,et al.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. , 1998, Circulation.